John McEwan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Toxicology top 10%
Papers in
-
- Asymmetric Synthesis and Catalysis 3
- Chemical synthesis and alkaloids 2
- Click Chemistry and Applications 1
-
- Porphyrin Metabolism and Disorders 2
- Prion Diseases and Protein Misfolding 1
- Co-authors
- Gregory Russell‐Jones (4 shared papers)Kirsten J. McTavish (3 shared papers)David P. Nowotnik (2 shared papers)John Rice (1 shared paper)Margaret A. Brimble (5 shared papers)Peter Turner (2 shared papers)Richard Elliott (1 shared paper)D. Scott Stewart (1 shared paper)
- Journals
- Tetrahedron Asymmetry (3 papers)Bioconjugate Chemistry (1 paper)Journal of drug targeting (1 paper)Journal of Inorganic Biochemistry (1 paper)Tumor Biology (1 paper)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
John McEwan
11 papers receiving 498 citations
Peers
Comparison fields: 5 of 65
- Biomaterials 111
- Toxicology 26
- Organic Chemistry 158
- Rheumatology 55
- Molecular Biology 221
Countries citing papers authored by John McEwan
This map shows the geographic impact of John McEwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McEwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McEwan more than expected).
Fields of papers citing papers by John McEwan
This network shows the impact of papers produced by John McEwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McEwan. The network helps show where John McEwan may publish in the future.
Co-authors
The 9 scholars most cited alongside John McEwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 346 | |
| 2 | 1999 | 45 | |
| 3 | 2010 | 28 | |
| 4 | 1997 | 22 | |
| 5 | 2009 | 19 | |
| 6 | 1998 | 17 | |
| 7 | 2000 | 15 | |
| 8 | 1998 | 13 | |
| 9 | 2012 | 2 | |
| 10 | 2000 | 2 | |
| 11 | 2006 | 1 |
About John McEwan
John McEwan is a scholar working on Organic Chemistry, Molecular Biology, Toxicology, Rheumatology and Oncology, having authored 11 papers that have together received 510 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), Folate and B Vitamins Research (3 papers), Asymmetric Synthesis and Catalysis (3 papers), Cancer-related Molecular Pathways (2 papers), Porphyrin Metabolism and Disorders (2 papers), Chemical synthesis and alkaloids (2 papers), Click Chemistry and Applications (1 paper) and Prion Diseases and Protein Misfolding (1 paper). The work is most often cited by research in Biomaterials (111 citations), Toxicology (26 citations), Organic Chemistry (158 citations), Rheumatology (55 citations) and Molecular Biology (221 citations). John McEwan has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Gregory Russell‐Jones, Kirsten J. McTavish, David P. Nowotnik, John Rice, Margaret A. Brimble, Peter Turner, Richard Elliott, D. Scott Stewart and Kyle Thurmond. Their work appears in journals such as Tetrahedron Asymmetry, Bioconjugate Chemistry, Journal of drug targeting, Journal of Inorganic Biochemistry and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.